Patents by Inventor Toshihiro Sinosaki

Toshihiro Sinosaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for treating or preventing glomerulopathy
    Patent number: 6878739
    Abstract: A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): wherein, for example, R1 and R2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R3 is 1,4-phenylene and 2,5-thiophendiyl; R4 is the substituents represented by the formula, etc.: wherein R5 is hydrogen atom, optionally substituted amino, etc.; and Y is NHOH or OH, its optically active substance, their pharmaceutically acceptable salt, or hydrate thereof.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: April 12, 2005
    Assignee: Shionogi & Co., Ltd.
    Inventors: Hidetake Kurihara, Fumihiko Watanabe, Yoshinori Tamura, Toshihiro Sinosaki
  • Composition for treating or preventing glomerulopathy
    Publication number: 20030078434
    Abstract: A composition for treating or preventing glomerulopathy which contains a compound of the formula (1): 1
    Type: Application
    Filed: June 6, 2002
    Publication date: April 24, 2003
    Applicant: Shionogi & Co., Ltd.
    Inventors: Hidetake Kurihara, Fumihiko Watanabe, Yoshinori Tamura, Toshihiro Sinosaki
  • Therapeutic or prophylactic agent for glomerulopathy
    Patent number: 6423729
    Abstract: A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): wherein, for example, R1 and R2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R3 is 1,4-phenylene and 2,5-thiophendiyl; R4 is the substituents represented by the formula, etc.: wherein R6 is hydrogen atom, optionally substituted amino, etc.; and Y is NHOH or OH, its optically active substance, their pharmaceutically acceptable salt, or hydrate thereof.
    Type: Grant
    Filed: December 30, 1999
    Date of Patent: July 23, 2002
    Assignee: Shionogi & Co., Ltd.
    Inventors: Hidetake Kurihara, Fumihiko Watanabe, Yoshinori Tamura, Toshihiro Sinosaki